Call for Abstract

35th Euro Congress on Neurologists and Psychiatrists, will be organized around the theme “Bridging Minds, Advancing Neuroscience, Transforming Mental Health”

Euro Neuro 2026 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Euro Neuro 2026

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

The transformative role of artificial intelligence, machine learning, and digital technologies in neurological and psychiatric care. Topics include AI-assisted diagnostics, predictive analytics, digital biomarkers, clinical decision support systems, and personalized treatment approaches. Participants will discover how emerging technologies are improving patient outcomes and reshaping healthcare delivery. The session also highlights ethical considerations and future innovations in brain health research. Researchers, clinicians, and technology experts are encouraged to contribute their findings.Machine Learning in Healthcare

  • AI-Assisted Diagnostics
  • Digital Biomarkers
  • Predictive Analytics
  • Clinical Decision Support Systems
  • Healthcare Data Science

Recent breakthroughs in understanding, diagnosing, and treating Alzheimer's and Parkinson's diseases. Discussions will cover disease mechanisms, biomarkers, genetics, early detection, and emerging therapies. Researchers will present advances aimed at slowing disease progression and improving patient quality of life. The session encourages multidisciplinary collaboration to address the growing global burden of neurodegenerative disorders. Novel clinical and translational research findings are highly welcomed.

• Alzheimer's Disease Research
Parkinson's Disease Innovations
• Neurodegeneration Mechanisms
• Biomarkers in Neurodegeneration
• Novel Therapeutic Strategies

This provides a platform for presenting rare neurological and psychiatric disorders, unusual clinical findings, and complex diagnostic cases. Participants can share innovative approaches to diagnosis, treatment, and patient management. The session aims to improve awareness and understanding of uncommon conditions that often require multidisciplinary expertise. Clinical case studies and real-world experiences are highly encouraged. It offers valuable learning opportunities for clinicians and researchers alike.

  • Rare Neurological Disorders
  • Rare Psychiatric Conditions
  • Challenging Case Studies
  • Diagnostic Innovations
  • Clinical Decision-Making

Translational Neuroscience and Therapeutic Innovations  bridges laboratory discoveries and clinical applications in neuroscience. It highlights translational research that advances new therapies, diagnostic tools, and treatment strategies for neurological and psychiatric disorders. Researchers will discuss how scientific discoveries move from bench to bedside to improve patient outcomes. The track promotes collaboration between basic scientists, clinicians, and industry professionals. Emerging therapeutic technologies and interventions will be explored.

Translational Brain Research
• Novel Therapeutics
• Drug Development
• Clinical Translation
• Experimental Medicine

Brain-Computer Interfaces and Neurotechnology examines personalized approaches to diagnosing and treating neurological and psychiatric disorders. Topics include genomics, pharmacogenomics, biomarkers, and individualized treatment strategies. Participants will explore how precision medicine is improving healthcare outcomes through targeted interventions. The session highlights innovations that support patient-centered care and evidence-based treatment decisions. Contributions from clinical and translational researchers are encouraged.

• Precision Neurology
• Precision Psychiatry
• Genomic Medicine
• Pharmacogenomics
• Personalized Therapeutics

Brain-Computer Interfaces and Neurotechnology explores cutting-edge neurotechnologies that enable communication between the brain and external devices. Discussions will focus on neural interfaces, neuroprosthetics, wearable technologies, and assistive systems designed to enhance patient care and quality of life. Researchers will present advancements that are revolutionizing the understanding and treatment of neurological disorders. The session highlights innovations that bridge neuroscience, engineering, and clinical practice. Contributions from academia, healthcare, and industry are welcomed.

• Brain-Computer Interfaces
Neural Engineering
• Neuroprosthetics
• Neural Signal Processing
• Assistive Technologies

The Digital Mental Health has growing role of digital platforms in mental healthcare delivery. Topics include telepsychiatry, mobile health applications, digital therapeutics, and remote patient monitoring. Participants will discuss opportunities to improve access to care while addressing ethical, clinical, and technological challenges. The track highlights innovative approaches to supporting mental well-being in the digital age. Research and practical experiences are encouraged.

Telepsychiatry
• Digital Therapeutics
• Remote Patient Monitoring
• Virtual Care Models
• Digital Well-Being

Neuroimaging and Advanced Diagnostics focuses on modern imaging technologies and diagnostic tools used to understand brain structure and function. Sessions will explore MRI, PET, functional imaging, neurodiagnostics, and advanced analytical techniques. Researchers will present innovations that enhance disease detection and treatment planning. The track aims to improve diagnostic accuracy and patient outcomes. Contributions from clinicians and imaging specialists are invited.

• Magnetic Resonance Imaging
Functional Neuroimaging
• PET Imaging
• Brain Mapping

Emerging Therapeutics and Neuropharmacology advances in pharmacological and therapeutic approaches for neurological and psychiatric disorders. Discussions will cover novel drug development, targeted therapies, treatment optimization, and clinical trials. Researchers will present innovative strategies aimed at improving efficacy and safety. The session encourages collaboration between scientists, clinicians, and pharmaceutical experts. Emerging therapeutic breakthroughs are a major focus.

Neuropharmacology
• Drug Discovery
• Clinical Trials
• Targeted Therapies
 

This track explores the causes, diagnosis, and treatment of common mood and anxiety disorders. Sessions will address biological, psychological, and social factors influencing mental health outcomes. Researchers will discuss innovative therapies, prevention strategies, and patient-centered care approaches. The track aims to advance understanding and improve clinical management. Contributions from mental health professionals and researchers are welcomed.

  • Anxiety Disorders
  • Major Depression
  • Bipolar Disorder
  • Mood Regulation
  • Psychological Interventions
  • Mental Health Outcomes

This session focuses on the neural mechanisms underlying cognition, behavior, memory, learning, and decision-making. Participants will explore advances in understanding brain function and cognitive processes. Research spanning experimental, clinical, and computational neuroscience will be presented. The track promotes interdisciplinary collaboration to uncover the complexities of human cognition. Emerging discoveries in cognitive science are encouraged.

  • Memory and Learning
  • Cognitive Function
  • Decision-Making
  • Behavioral Neuroscience

This track addresses current strategies for preventing, diagnosing, and managing stroke. Topics include acute interventions, rehabilitation techniques, risk reduction, and long-term recovery. Researchers will present innovations aimed at improving patient outcomes and quality of life. The session highlights multidisciplinary approaches to stroke care. Clinical and translational studies are encouraged.

  • Stroke Prevention
  • Acute Stroke Care
  • Rehabilitation Strategies
  • Neurovascular Disorders

This track explores the diagnosis, management, and research advancements in autism spectrum and related neurodevelopmental disorders. Discussions will include genetics, early intervention, behavioral therapies, and developmental neuroscience. Researchers will examine strategies to improve outcomes across the lifespan. The session encourages multidisciplinary perspectives and innovative research. Contributions from clinicians and educators are welcomed.

This session focuses on mental health challenges affecting children and adolescents. Topics include developmental disorders, behavioral conditions, emotional well-being, and early psychiatric interventions. Researchers will present evidence-based approaches to diagnosis and treatment. The track highlights the importance of early identification and prevention. Contributions aimed at improving youth mental health are encouraged.

This track examines the relationship between sleep and neurological as well as psychiatric health. Discussions will address sleep disorders, circadian rhythms, cognitive function, and disease risk. Researchers will present advances in diagnosis, treatment, and sleep science. The session highlights the critical role of sleep in maintaining brain health. Clinical and research contributions are welcomed.

  • Sleep Medicine
  • Insomnia Research
  • Circadian Rhythm Disorders
  • Sleep and Cognition

This track focuses on rehabilitation approaches that support recovery following neurological injury or disease. Topics include physical rehabilitation, cognitive recovery, assistive technologies, and patient-centered care. Researchers will discuss innovative interventions designed to maximize functional outcomes. The session promotes multidisciplinary collaboration in rehabilitation science. Emerging therapeutic approaches are encouraged.

  • Neuro rehabilitation
  • Motor Recovery
  • Functional Recovery
  • Rehabilitation Innovation

 

This session explores the role of the immune system in neurological diseases. Topics include neuroinflammation, autoimmune disorders, multiple sclerosis, and emerging immunotherapies. Researchers will discuss mechanisms driving disease progression and therapeutic innovation. The track highlights rapidly evolving discoveries in neuroimmune interactions. Contributions from both basic and clinical researchers are encouraged.

  • Neuroinflammation
  • Multiple Sclerosis
  • Autoimmune Neurology
  • Neuroimmune Mechanisms

This track focuses on the identification and validation of biomarkers for neurological and psychiatric disorders. Discussions will cover molecular, genetic, imaging, and digital biomarkers that support early diagnosis and precision care. Researchers will present advances that improve disease prediction and monitoring. The session promotes innovation in personalized healthcare. Emerging biomarker research is highly encouraged.

  • Molecular Biomarkers
  • Genetic Biomarkers
  • Imaging Biomarkers
  • Digital Biomarkers

This track examines the biological, psychological, and social aspects of addiction and substance use disorders. Topics include prevention, diagnosis, treatment, recovery, and public health approaches. Researchers will explore innovative interventions and evidence-based care models. The session highlights strategies to reduce the burden of addiction worldwide. Contributions from clinicians and researchers are welcomed.

This session explores the complex relationship between the gut microbiome, brain function, and mental health. Topics include microbiome research, neuroimmune interactions, metabolic pathways, and psychiatric outcomes. Researchers will discuss emerging evidence linking gut health to neurological and mental disorders. The track highlights novel therapeutic opportunities and interdisciplinary collaboration. Contributions from both clinical and basic science researchers are encouraged.